Document Detail

Inotropic therapy is unsuccessful: wrong conceptual target or wrong therapeutic tools?
MedLine Citation:
PMID:  14635366     Owner:  NLM     Status:  MEDLINE    
Since a depressed contractility has long been considered the primary defect in patients with heart failure, the use of inotropic agents has been regarded as a logical approach to treat this syndrome. Despite this conceptual framework, these drugs have not yet established themselves in the treatment of chronic heart failure and their long-term use was associated with an excessive mortality while the short-term intravenous administration in critically ill patients produced only acute hemodynamic results without a stable clinical improvement. At least four mechanisms could explain this discrepancy: their arrhythmogenicity, their direct cardiotoxic effects, the downregulation of the beta-adrenoreceptors, and the energetic cost of inotropic intervention. Moreover, in many patients with ischemic cardiomyopathy the reduction in contractility could be considered as a compensatory mechanism since hibernation is able to decrease the metabolic requirements of the heart. The contractile force of the heart can be augmented not only by an increased availability of intracellular calcium for troponin C but also by an increased sensitivity of the contractile proteins to calcium. A new class of inotropes working with this mechanism is now available and could represent a real improvement in this challenging therapeutic area.
Claudio Rapezzi; Enrica Perugini; Michela Santi; Giovanni Bracchetti; Angelo Branzi
Related Documents :
22959106 - Free floating left atrial ball thrombus: a rare cause of stroke.
23314006 - Epidermal growth factor and growth hormone-releasing peptide-6: combined therapeutic ap...
9054836 - Role of myocyte nitric oxide in beta-adrenergic hyporesponsiveness in heart failure.
11070186 - Adrenomedullin and myocardial contractility in the rat.
3788766 - Effect of fluosol-da on infarct morphology and vulnerability to ventricular arrhythmia.
17353496 - N-terminal pro-b-type natriuretic peptide as a diagnostic test for ventricular dysfunct...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Italian heart journal : official journal of the Italian Federation of Cardiology     Volume:  4 Suppl 2     ISSN:  1129-471X     ISO Abbreviation:  Ital Heart J     Publication Date:  2003 May 
Date Detail:
Created Date:  2003-11-25     Completed Date:  2004-03-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  100909716     Medline TA:  Ital Heart J     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  22S-26S     Citation Subset:  IM    
Institute of Cardiology, University of Bologna, Bologna, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiotonic Agents / therapeutic use*
Heart Failure / drug therapy,  physiopathology
Medication Errors*
Myocardial Contraction / drug effects,  physiology
Risk Assessment
Treatment Failure
Reg. No./Substance:
0/Cardiotonic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Infusion therapy in severe heart failure. A reappraisal.
Next Document:  Is calcium sensitization the best strategy to improve myocardial contractility in acute heart failur...